Aspiriant LLC’s Vanguard Value ETF VTV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.5M Sell
99,384
-1,223
-1% -$245K 0.56% 30
2025
Q4
$19.2M Sell
100,607
-1,777
-2% -$334K 0.55% 32
2025
Q3
$19.1M Sell
102,384
-1,679
-2% -$304K 0.58% 29
2025
Q2
$18.4M Buy
104,063
+16,204
+18% +$2.74M 0.58% 29
2025
Q1
$15.2M Sell
87,859
-1,104
-1% -$193K 0.53% 28
2024
Q4
$15.1M Sell
88,963
-280
-0.3% -$49.1K 0.54% 28
2024
Q3
$15.6M Sell
89,243
-683
-0.8% -$114K 0.59% 27
2024
Q2
$14.4M Buy
89,926
+3,952
+5% +$632K 0.59% 28
2024
Q1
$14M Sell
85,974
-4,484
-5% -$691K 0.58% 29
2023
Q4
$13.5M Sell
90,458
-10,953
-11% -$1.54M 0.61% 28
2023
Q3
$14M Sell
101,411
-1,747
-2% -$250K 0.72% 24
2023
Q2
$14.7M Sell
103,158
-2,750
-3% -$382K 0.74% 23
2023
Q1
$14.6M Sell
105,908
-4,844
-4% -$680K 0.77% 22
2022
Q4
$15.5M Buy
110,752
+70,837
+177% +$9.76M 0.79% 21
2022
Q3
$4.93M Sell
39,915
-7,622
-16% -$1.03M 0.24% 49
2022
Q2
$6.27M Buy
47,537
+10,848
+30% +$1.53M 0.3% 43
2022
Q1
$5.42M Buy
36,689
+1,716
+5% +$250K 0.3% 47
2021
Q4
$5.14M Sell
34,973
-583
-2% -$83.3K 0.27% 48
2021
Q3
$4.81M Buy
35,556
+574
+2% +$79.9K 0.28% 45
2021
Q2
$4.81M Buy
34,982
+11,045
+46% +$1.52M 0.27% 39
2021
Q1
$3.15M Buy
23,937
+12,740
+114% +$1.6M 0.2% 47
2020
Q4
$1.33M Sell
11,197
-3,644
-25% -$410K 0.09% 83
2020
Q3
$1.55M Sell
14,841
-1,498
-9% -$157K 0.12% 79
2020
Q2
$1.63M Buy
16,339
+4,492
+38% +$441K 0.15% 61
2020
Q1
$1.05M Buy
11,847
+2,140
+22% +$235K 0.1% 79
2019
Q4
$1.16M Buy
9,707
+610
+7% +$70.4K 0.11% 85
2019
Q3
$1.02M Hold
9,097
0.09% 107
2019
Q2
$1.01M Sell
9,097
-2,221
-20% -$242K 0.08% 108
2019
Q1
$1.22M Buy
11,318
+2,386
+27% +$251K 0.1% 98
2018
Q4
$877K Sell
8,932
-774
-8% -$81.4K 0.07% 110
2018
Q3
$1.08M Buy
9,706
+907
+10% +$99.1K 0.09% 103
2018
Q2
$914K Hold
8,799
0.08% 111
2018
Q1
$908K Buy
8,799
+4,239
+93% +$455K 0.08% 111
2017
Q4
$485K Sell
4,560
-3,794
-45% -$391K 0.14% 51
2017
Q3
$834K Buy
8,354
+56
+0.7% +$5.48K 0.07% 119
2017
Q2
$801K Hold
8,298
0.07% 122
2017
Q1
$791K Buy
8,298
+388
+5% +$36.9K 0.07% 128
2016
Q4
$736K Hold
7,910
0.07% 121
2016
Q3
$688K Sell
7,910
-90
-1% -$7.84K 0.07% 123
2016
Q2
$680K Hold
8,000
0.06% 120
2016
Q1
$659K Hold
8,000
0.06% 118
2015
Q4
$652K Sell
8,000
-12,622
-61% -$1.03M 0.07% 51
2015
Q3
$1.68M Buy
20,622
+6,186
+43% +$503K 0.14% 42
2015
Q2
$1.2M Buy
14,436
+7,613
+112% +$649K 0.12% 43
2015
Q1
$571K Sell
6,823
-236
-3% -$19.8K 0.07% 56
2014
Q4
$596K Hold
7,059
0.08% 56
2014
Q3
$573K Sell
7,059
-4
-0.1% -$327 0.08% 47
2014
Q2
$572K Sell
7,063
-2,420
-26% -$192K 0.08% 59
2014
Q1
$741K Hold
9,483
0.11% 59
2013
Q4
$724K Sell
9,483
-1,442
-13% -$106K 0.11% 49
2013
Q3
$762K Buy
10,925
+1,161
+12% +$81.8K 0.14% 31
2013
Q2
$660K Buy
+9,764
New +$660K 0.1% 40

Other funds holding VTV

Aspiriant LLC's VTV Position: Q1 2026 in Review

Aspiriant LLC reduced its Vanguard Value ETF (VTV) stake by 1.2% in Q1 2026, selling an estimated $245K and leaving 99,384 shares worth $19.5M. The position accounts for 0.56% of the portfolio, ranked #30.

Aspiriant LLC first reported a position in VTV in Q2 2013 and has held it in 52 quarters since. 2,697 funds tracked by Wall St. Rank hold VTV as of Q1 2026.

  • Aspiriant LLC held 99,384 shares of Vanguard Value ETF worth $19.5M as of Q1 2026.
  • Aspiriant LLC sold 1,223 Vanguard Value ETF shares in Q1 2026, an estimated $245K.
  • Vanguard Value ETF made up 0.56% of Aspiriant LLC's portfolio in Q1 2026, its #30 holding.
  • Aspiriant LLC first reported a position in Vanguard Value ETF in Q2 2013 and has held it in 52 quarters since.
  • 2,697 funds tracked by Wall St. Rank held Vanguard Value ETF as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.